Dr. Ole Henrik Brekke
Board member
oncology
Nextera
Norway
Biography
Dr. Ole Henrik Brekke joined the Nextera Board in 2009. Dr. Brekke is currently working as Director Business Development in LINK Medical Research. Ole Henrik’s scientific work has fostered significant understanding to the function of human antibodies and he is author of over 20 papers including Nature, PNAS and Nature Reviews in Drug Discovery, and is the inventor on several patents in recombinant antibody technology. He has been a senior scientist at UiO and National Institute of Public Health and has had R&D Director positions in Affitech and Dynal-Invitrogen. He was doing business development at Birkeland Innovation before joining Vaccibody in 2008 where he acted as CEO until 2015. Ole Henrik holds an M.Sc and a Ph.D from the Institute of Molecular Cell Biology, University of Oslo.
Research Interest
cancer antibodies
